Market Live: Nifty below 10,800, Sensex falls 200 pts; Infosys trades ex-dividend. Asian shares traded lower after Fed raises rates and signals more hikes ahead.
Buzzing: Shares of Cipla gained 2 percent as the company received final USFDA approval for Isoproterenol hydrochloride injection.
The company has received final approval for its abbreviated new drug application (ANDA) for Isoproterenol hydrochloride injection USP, 0.2mg/mL, single-use sterile Ampoule from the United States Food and Drug Administration (USFDA).
Click here To know about the Best Stock Advisory India
Cipla’s Isoproterenol hydrochloride injection is AP - rated generic therapeutic equivalent version of Hospira Inc’s Isuprel injection and is indicated for the treatment of cardiac problems and heart block.
Rupee Update: The rupee appreciated by 5 paise to 67.60 against the US dollar after the American currency weakened overseas.
Rupee Update: The rupee appreciated by 5 paise to 67.60 against the US dollar after the American currency weakened overseas.
Dealers said fresh selling of the greenback by banks and exporters backed up the rupee.
The dollar turned weak against other currencies overseas even after the US Federal Reserve lifted interest rates and signaled two more hikes this year and four in 2019.
Yesterday, the domestic unit ended 16 paise down to close at a near one-week low of 67.65 against the US currency on sustained dollar demand.
Market Update: Benchmark indices extended losses in the morning as the Sensex shed 192.61 points to 35,546.55, dragged by Infosys, Reliance Industries, ICICI Bank and TCS.
The Nifty slipped below 10,800 levels, falling 63.20 points to 10,793.50.
Market Opening: Benchmark indices started off trade on a weak note after investors digested US Federal Reserve's rate hike.
The 30-share BSE Sensex fell 93.70 points to 35,645.46 and the 50-share NSE Nifty declined 35.30 points to 10,821.40.
Infosys lost 2 percent.
Click here to get Free Commodity Tips
The dollar turned weak against other currencies overseas even after the US Federal Reserve lifted interest rates and signaled two more hikes this year and four in 2019.
Yesterday, the domestic unit ended 16 paise down to close at a near one-week low of 67.65 against the US currency on sustained dollar demand.
Market Update: Benchmark indices extended losses in the morning as the Sensex shed 192.61 points to 35,546.55, dragged by Infosys, Reliance Industries, ICICI Bank and TCS.
The Nifty slipped below 10,800 levels, falling 63.20 points to 10,793.50.
Market Opening: Benchmark indices started off trade on a weak note after investors digested US Federal Reserve's rate hike.
The 30-share BSE Sensex fell 93.70 points to 35,645.46 and the 50-share NSE Nifty declined 35.30 points to 10,821.40.
Infosys lost 2 percent.
Click here to get Free Commodity Tips
Vedanta, BPCL, HPCL, IOC, SBI, Axis Bank, ICICI Bank, and Tata Steel are under pressure.
Lupin, Cipla, Aurobindo, Bharti Airtel and HDFC Bank are early gainers.
The nifty Midcap index dropped 36 points and Nifty Bank slipped 70 points.
Dish TV, Vakrangee, Granules India, gained up to 5 percent.
NBCC, Shree Renuka, Bhansali Engineering, Oberoi Realty, Mindtree, Future Consumer, SBI Life, Adani Power, Suzlon, Reliance Power, Canara Bank, PNB, Gammon Infra, Videocon and GMR Infrastructure declined up to 5 percent.
Lupin, Cipla, Aurobindo, Bharti Airtel and HDFC Bank are early gainers.
The nifty Midcap index dropped 36 points and Nifty Bank slipped 70 points.
Dish TV, Vakrangee, Granules India, gained up to 5 percent.
NBCC, Shree Renuka, Bhansali Engineering, Oberoi Realty, Mindtree, Future Consumer, SBI Life, Adani Power, Suzlon, Reliance Power, Canara Bank, PNB, Gammon Infra, Videocon and GMR Infrastructure declined up to 5 percent.
-------------------------------------------------------------------------------------------------------------------------
For More Information regarding Stock market news updates & Commodity Tips, Intraday Calls, Share Market Tips contact us at +91-8305596871 or simply fill our Free Trial registration form linked in this blog.
No comments:
Post a Comment